메뉴 건너뛰기




Volumn 26, Issue 10, 2010, Pages 2507-2516

Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments

Author keywords

Diabetic peripheral neuropathic pain; Duloxetine; Healthcare costs; Opioid utilization

Indexed keywords

AMFEBUTAMONE; CODEINE; DEXTROPROPOXYPHENE; DULOXETINE; GABAPENTIN; HYDROCODONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PREGABALIN; TRAMADOL; VENLAFAXINE;

EID: 77956781747     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.518438     Document Type: Article
Times cited : (11)

References (32)
  • 1
    • 34548104636 scopus 로고    scopus 로고
    • Diabetic peripheral neuropathic pain: Recognition and management
    • Cole BE. Diabetic peripheral neuropathic pain: recognition and management. Pain Med 2007;8(Suppl 2):S27-32
    • (2007) Pain Med , vol.8 , Issue.SUPPL. 2
    • Cole, B.E.1
  • 2
    • 33645657561 scopus 로고    scopus 로고
    • Diabetic peripheral neuropathic pain: Clinical and quality-of-life issues
    • Argoff CE, Cole BE, Fishbain DA, et al. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 2006;81:S3-11
    • (2006) Mayo Clin Proc , vol.81
    • Argoff, C.E.1    Cole, B.E.2    Fishbain, D.A.3
  • 4
    • 22144469481 scopus 로고    scopus 로고
    • Management of diabetic peripheral neuropathy
    • Boulton AJM. Management of diabetic peripheral neuropathy. Clin Diabet 2005;23:9-15
    • (2005) Clin Diabet , vol.23 , pp. 9-15
    • Ajm, B.1
  • 5
    • 20144389536 scopus 로고    scopus 로고
    • Diabetic neuropathies: A statement by the American Diabetes Association
    • Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-962
    • (2005) Diabetes Care , vol.28 , pp. 956-962
    • Boulton, A.J.1    Vinik, A.I.2    Arezzo, J.C.3
  • 6
    • 0033988613 scopus 로고    scopus 로고
    • Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life
    • Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000; 47:123-128
    • (2000) Diabetes Res Clin Pract , vol.47 , pp. 123-128
    • Galer, B.S.1    Gianas, A.2    Jensen, M.P.3
  • 7
    • 33845221482 scopus 로고    scopus 로고
    • Burden of illness in painful diabetic peripheral neuropathy: The patients' perspectives
    • Gore M, Brandenburg NA, Hoffman DL, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain 2006;7: 892-900
    • (2006) J Pain , vol.7 , pp. 892-900
    • Gore, M.1    Brandenburg, N.A.2    Hoffman, D.L.3
  • 8
    • 33947310739 scopus 로고    scopus 로고
    • Diabetic painful neuropathy: Current and future treatment options
    • Chong MS, Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs 2007;67:569-585
    • (2007) Drugs , vol.67 , pp. 569-585
    • Chong, M.S.1    Hester, J.2
  • 9
    • 45249098499 scopus 로고    scopus 로고
    • Managing painful neuropathy in diabetes
    • Jude EB, Jacob K. Managing painful neuropathy in diabetes. Pol Arch Med Wewn 2008;118:260-261
    • (2008) Pol Arch Med Wewn , vol.118 , pp. 260-261
    • Jude, E.B.1    Jacob, K.2
  • 10
    • 2342466734 scopus 로고    scopus 로고
    • Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
    • Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
    • (2004) Diabetes Care , vol.27 , pp. 1047-1053
    • Wild, S.1    Roglic, G.2    Green, A.3
  • 11
    • 34548144817 scopus 로고    scopus 로고
    • Diabetic peripheral neuropathic pain. Consensus guidelines for treatment
    • June
    • Diabetic peripheral neuropathic pain. Consensus guidelines for treatment. J Fam Pract 2006;June (Suppl):3-19
    • (2006) J Fam Pract , Issue.SUPPL. , pp. 3-19
  • 12
    • 33645689140 scopus 로고    scopus 로고
    • Consensus guidelines: Treatment planning and options. Diabetic peripheral neuropathic pain
    • Argoff CE, Backonja MM, Belgrade MJ, et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc 2006;81:S12-25
    • (2006) Mayo Clin Proc , vol.81
    • Argoff, C.E.1    Backonja, M.M.2    Belgrade, M.J.3
  • 13
    • 33646901548 scopus 로고    scopus 로고
    • Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain
    • Wu EQ, Birnbaum HG, Mareva MN, et al. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain. J Pain 2006;7:399-407
    • (2006) J Pain , vol.7 , pp. 399-407
    • Wu, E.Q.1    Birnbaum, H.G.2    Mareva, M.N.3
  • 14
    • 33750396100 scopus 로고    scopus 로고
    • New perspectives on the management of diabetic peripheral neuropathic pain
    • Jensen TS, Backonja MM, Hernandez JS, et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006;3:108-119
    • (2006) Diab Vasc Dis Res , vol.3 , pp. 108-119
    • Jensen, T.S.1    Backonja, M.M.2    Hernandez, J.S.3
  • 15
    • 38049136702 scopus 로고    scopus 로고
    • Diabetic neuropathy: New strategies for treatment
    • Varkonyi T, Kempler P. Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab 2008;10:99-108
    • (2008) Diabetes Obes Metab , vol.10 , pp. 99-108
    • Varkonyi, T.1    Kempler, P.2
  • 16
    • 34447624308 scopus 로고    scopus 로고
    • Effects of treatments for symptoms of painful diabetic neuropathy: Systematic review
    • Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 2007;335:87
    • (2007) BMJ , vol.335 , pp. 87
    • Wong, M.C.1    Chung, J.W.2    Wong, T.K.3
  • 17
    • 41949119381 scopus 로고    scopus 로고
    • An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy
    • Zin CS, Nissen LM, Smith MT, et al. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 2008;22:417-442
    • (2008) CNS Drugs , vol.22 , pp. 417-442
    • Zin, C.S.1    Nissen, L.M.2    Smith, M.T.3
  • 18
    • 34548079523 scopus 로고    scopus 로고
    • Safety profile of treatment in diabetic peripheral neuropathic pain
    • Robinson-Papp J, Simpson DM. Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Med 2007;8(Suppl 2):S43-9
    • (2007) Pain Med , vol.8 , Issue.SUPPL. 2
    • Robinson-Papp, J.1    Simpson, D.M.2
  • 20
    • 49049087890 scopus 로고    scopus 로고
    • Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: The TROUP study
    • Sullivan MD, Edlund MJ, Fan MY, et al. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 2008;138:440-449
    • (2008) Pain , vol.138 , pp. 440-449
    • Sullivan, M.D.1    Edlund, M.J.2    Fan, M.Y.3
  • 21
    • 0026639706 scopus 로고
    • Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
    • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613-619
    • (1992) J Clin Epidemiol , vol.45 , pp. 613-619
    • Deyo, R.A.1    Cherkin, D.C.2    Ciol, M.A.3
  • 22
    • 54449092157 scopus 로고    scopus 로고
    • Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: Results from the TROUP study
    • Braden JB, Fan MY, Edlund MJ, et al. Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain 2008;9:1026-1035
    • (2008) J Pain , vol.9 , pp. 1026-1035
    • Braden, J.B.1    Fan, M.Y.2    Edlund, M.J.3
  • 24
    • 77951622706 scopus 로고
    • The central role of the propensity score in observational studies for causal effects
    • Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55
    • (1983) Biometrika , vol.70 , pp. 41-55
    • Rosenbaum, P.R.1    Rubin, D.B.2
  • 25
    • 3242749075 scopus 로고    scopus 로고
    • A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control 1997-2002
    • Gilson AM, Ryan KM, Joranson DE, et al. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 2004;28:176-188
    • (2004) J Pain Symptom Manage , vol.28 , pp. 176-188
    • Gilson, A.M.1    Ryan, K.M.2    Joranson, D.E.3
  • 26
    • 75149184679 scopus 로고    scopus 로고
    • Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain
    • Wu N, Chen S, Boulanger L, et al. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain. J Med Econ 2009;12:192-202
    • (2009) J Med Econ , vol.12 , pp. 192-202
    • Wu, N.1    Chen, S.2    Boulanger, L.3
  • 27
    • 33947675848 scopus 로고    scopus 로고
    • The burden of diabetes and its complications: Trends and implications for intervention
    • Chaturvedi N. The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res Clin Pract 2007;76(Suppl 1): S3-S12
    • (2007) Diabetes Res Clin Pract , vol.76 , Issue.SUPPL. 1
    • Chaturvedi, N.1
  • 28
    • 68749108405 scopus 로고    scopus 로고
    • A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients
    • Boulanger L, Zhao Y, Bao Y, et al. A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients. BMC Health Serv Res 2009;9:111
    • (2009) BMC Health Serv Res , vol.9 , pp. 111
    • Boulanger, L.1    Zhao, Y.2    Bao, Y.3
  • 29
    • 34548094313 scopus 로고    scopus 로고
    • Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: A review
    • Barrett AM, Lucero MA, Le T, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007;8(Suppl 2):S50-62
    • (2007) Pain Med , vol.8 , Issue.SUPPL. 2
    • Barrett, A.M.1    Lucero, M.A.2    Le, T.3
  • 30
    • 0037214915 scopus 로고    scopus 로고
    • Treatment of symptomatic diabetic neuropathy
    • Boulton AJ. Treatment of symptomatic diabetic neuropathy. Diabetes Metab Res Rev 2003;19(Suppl 1):S16-21
    • (2003) Diabetes Metab Res Rev , vol.19 , Issue.SUPPL. 1
    • Boulton, A.J.1
  • 31
    • 0034438775 scopus 로고    scopus 로고
    • NSAID gastrointestinal toxicity
    • Cryer B. NSAID gastrointestinal toxicity. Curr Opin Gastroenterol 2000;16: 495-502
    • (2000) Curr Opin Gastroenterol , vol.16 , pp. 495-502
    • Cryer, B.1
  • 32
    • 33846643628 scopus 로고    scopus 로고
    • The financial costs of healthcare treatment for people with type 1 or type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy
    • Currie CJ, Poole CD, Woehl A, et al. The financial costs of healthcare treatment for people with type 1 or type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med 2007; 24:187-194
    • (2007) Diabet Med , vol.24 , pp. 187-194
    • Currie, C.J.1    Poole, C.D.2    Woehl, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.